Influence of Various Media on the Dissolution Profiles of Immediate-Release Quetiapine Tablets in India

被引:0
|
作者
Shah, Zubin [1 ]
Londhe, Vaishali [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Bombay, Maharashtra, India
来源
DISSOLUTION TECHNOLOGIES | 2016年 / 23卷 / 01期
关键词
Quetiapine tablets; in vitro dissolution; milk; curd; egg; beverages; antacids;
D O I
10.14227/DT230116P42
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dissolution testing was performed to evaluate the drug release from tablets. To mimic actual in vivo conditions, various foods and beverages were added to the dissolution media, and the release profiles were investigated. Indian people tend to have milk, curds, or eggs during their meals and then take their medications immediately after meals, whereas Americans tend to take medications with beverages. To evaluate drug release profiles in the presence and absence of these foods and beverages, in vitro dissolution testing was conducted using three different Indian quetiapine fumarate tablet brands. The effect on drug release was evaluated by adding 100 mL milk (3.1% protein), 100 g curd (4.1% protein), and 50 g raw and boiled egg white individually to 0.1 N HCl, and the release was compared with that in only 0.1 N HCl as per the Indian Pharmacopeia (IP) (1). The study was conducted for 3 h in triplicate, and the results show a significant difference among the brands in each medium with food. The maximum release obtained for each brand in 0.1 N HCl was 90%; in the presence of milk, curd, raw egg, and boiled egg it was approximately 7.06%, 2.42%, 29.56%, 24.08%, respectively, indicating that the drug was unavailable. Studies were also conducted with beverages and antacids; 200 mL of Thums Up, Sprite, and ENO were added individually to 0.1 N HCl and the release results compared. Results indicate a decrease of around 15% in availability in the presence of beverages and a 37% decrease in the presence of antacids. The results were statistically compared using one-way ANOVA at its Q value (45 min).
引用
收藏
页码:42 / 46
页数:5
相关论文
共 50 条
  • [41] Patient outcomes after formulary conversion from immediate-release to extended-release glipizide tablets
    Leaf, E
    King, JO
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (05) : 454 - 456
  • [42] Lacosamide extended-release capsules are bioequivalent to lacosamide immediate-release tablets: Pharmacokinetic observations and simulations
    Wheless, James
    Gidal, Barry
    Gong, Lixin
    Lyu, Shaoqiong
    Zheng, Xun
    Li, Rong
    Chang, Wilson
    Tan, Marie
    EPILEPSY RESEARCH, 2024, 202
  • [43] An Investigation into the Influence of Experimental Conditions on In Vitro Drug Release from Immediate-Release Tablets of Levothyroxine Sodium and Its Relation to Oral Bioavailability
    Kocic, Ivana
    Homsek, Irena
    Dacevic, Mirjana
    Parojcic, Jelena
    Miljkovic, Branislava
    AAPS PHARMSCITECH, 2011, 12 (03): : 938 - 948
  • [44] An Investigation into the Influence of Experimental Conditions on In Vitro Drug Release from Immediate-Release Tablets of Levothyroxine Sodium and Its Relation to Oral Bioavailability
    Ivana Kocic
    Irena Homsek
    Mirjana Dacevic
    Jelena Parojcic
    Branislava Miljkovic
    AAPS PharmSciTech, 2011, 12 : 938 - 948
  • [45] Bilayer tablets with sustained-release metformin and immediate-release sitagliptin: preparation and in vitro/in vivo evaluation
    Ngoc Nha Thao Nguyen
    Duy Toan Pham
    Duc Tuan Nguyen
    Thi Thu Loan Trinh
    Journal of Pharmaceutical Investigation, 2021, 51 : 579 - 586
  • [46] A comparative multidose pharmacokinetic study of buspirone extended-release tablets with a reference immediate-release product
    Sakr, A
    Andheria, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (08): : 886 - 894
  • [47] 3D printing of immediate-release tablets containing olanzapine by filaments extrusion
    Bhatt, Ukti
    Malakar, Tushar Kanti
    Murty, Upadhyayula Suryanarayana
    Banerjee, Subham
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47 (08) : 1200 - 1208
  • [48] In Vitro–In Vivo Correlation for Gliclazide Immediate-Release Tablets Based on Mechanistic Absorption Simulation
    Sandra Grbic
    Jelena Parojcic
    Svetlana Ibric
    Zorica Djuric
    AAPS PharmSciTech, 2011, 12 : 165 - 171
  • [49] Thermal Extrusion 3D Printing for the Fabrication of Puerarin Immediate-Release Tablets
    Pingfei Li
    Haoyue Jia
    Shiming Zhang
    Yining Yang
    Haowei Sun
    Haoyu Wang
    Weisan Pan
    Fei Yin
    Xinggang Yang
    AAPS PharmSciTech, 21
  • [50] Differential effects of food on the bioavailability of controlled-release oxycodone tablets and immediate-release oxycodone solution
    Benziger, DP
    Kaiko, RF
    Miotto, JB
    Fitzmartin, RD
    Reder, RF
    Chasin, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (04) : 407 - 410